Psykiatri sydväst
Stockholm, Sweden
NCT Number: NCT01525576
In this trial, we test if adding an Internet-based booster program to regular Internet-based cognitive behavior therapy (ICBT) is effective for patients with obsessive-compulsive disorder (OCD).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Stockholm, Sweden
Written consent form. Completing ICBT in our previous study: Please see NCT01347099 for more details.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 week booster program + 2 additional weeks two months later for follow-up.
Time frame: 3 months before treatment, 3 weeks after treatment starts, 6 and 18 months after treatment has ended
Yale Brown Obsessive Compulsive Scale (Y-BOCS). Analysis will examine the frequency of relapse from remission between the groups. Furthermore, frequency of incremental cases of remission will be compared between the groups.
Time frame: 3 months before treatment, 6 and 18 months after treatment has ended
Obsessive Compulsive Scale - Revised (OCI-R)
Time frame: 3 months before treatment, 6 and 18 months after treatment has ended
Trimbos Institute Cost-assessment for Psychiatry (TIC-P)
Time frame: 3 months before treatment, 6 and 18 months after treatment has ended
Montgomery Asberg Depression Rating Scale
Time frame: 3 months before treatment, 6 and 18 months after treatment has ended
Euroqol
Karolinska Institutet
Other
Efficacy of an Internet-based Booster Program for Obsessive-compulsive Disorder: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05552014
Anxiety Disorders, Mental Disorders
Hefei, Anhui, China
View Trial DetailsNCT04967560
Anxiety Disorders, Mental Disorders
Zhengzhou, Henan, China
View Trial DetailsNCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsNCT04693351
Anxiety Disorders, Mental Disorders
Phoenix, Arizona, United States
View Trial Details